Trump Legalizes Crypto Investing – Why Capitalists Are Quietly Choosing BTC Miner's Cloud Mining with Up to 7% Daily Returns
While the public chases volatile Bitcoin and Ethereum prices, insiders are choosing a stable, high-return alternative: automated cloud mining.
What Is BTC Miner?
BTC Miner is a global cloud mining platform that lets anyone mine Bitcoin remotely—without owning expensive mining rigs or paying massive electricity bills. Investors simply select a hash-power contract, and BTC Miner handles everything through its AI-managed mining network powered by renewable energy.
Daily returns up to 7%
$500 free mining trial for new users
No hardware, no maintenance, zero hassle
Earnings paid daily in USD equivalents
Funds safely stored in Tier-1 banks, insured by AIG
BTC Miner transforms crypto mining into a simple, automated, and profitable process for everyone.
Why Capitalists Are Secretly Joining BTC Miner
Trump's new crypto law has opened the gates for institutional investors, but sophisticated players aren't relying solely on risky token investments. Instead, they're embracing BTC Miner cloud mining for one reason: stability.
Predictable Daily Returns : Earn up to 7% daily, independent of market volatility.
: Earn up to 7% daily, independent of market volatility. AI-Managed Efficiency : BTC Miner uses intelligent load balancing to maximize mining profitability.
: BTC Miner uses intelligent load balancing to maximize mining profitability. ESG Compliance : Powered by green energy to meet institutional sustainability standards.
: Powered by green energy to meet institutional sustainability standards. Top-Level Fund Security : Clients' funds are securely stored in Tier-1 banks, and their personal information is protected by SSL encryption. Every investment is protected by an AIG insurance policy, adding another layer of safety.
: Clients' funds are securely stored in Tier-1 banks, and their personal information is protected by SSL encryption. Every investment is protected by an AIG insurance policy, adding another layer of safety. Fully Regulated & Transparent: BTC Miner operates licensed mining farms with strict asset protection.
In short, BTC Miner delivers what institutional capital demands: stable, secure, and scalable profits in crypto.
Investors Speak – Real BTC Miner User Feedback
'I'm earning daily profits without having to sell my Bitcoin.'
— James K., Investor from Texas
'Started with the $500 trial and saw real profits within days. Zero risk, pure rewards.'
— Anna S., User from Germany
'Instant withdrawals, stable payouts. BTC Miner is how I generate passive crypto income.'
— Wei L., Business owner from Singapore
BTC Miner is building a strong reputation worldwide as the go-to choice for safe, profitable crypto investing.
How to Join BTC Miner and Start Earning Crypto Easily
Sign up: Go to https://btcminer.net and create a free account.
Claim $500 Free Trial: New users automatically receive $500 in mining credits. Choose a Mining Plan: Select short or long-term hash-power contracts. Sit Back and Earn: BTC Miner handles everything. Daily returns are automatic. Withdraw Anytime: Profits are paid daily and can be withdrawn instantly.
Referral Program: Invite friends and earn 7% from their mining profits and 2% from indirect referrals. Build your own mining network and grow your passive income.
The Smart Money Has Already Moved
With Trump's crypto-friendly law in place and billions of institutional dollars entering the market, cloud mining is the next frontier. BTC Miner offers a secure, stable, and fully automated way to grow wealth without chasing volatile token prices.
Stop trading. Start mining.
Let BTC Miner work for you 24/7.
👉 Join now at https://btcminer.net, claim your $500 free trial, and start earning up to 7% daily.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
7 minutes ago
- Mint
US layoffs: This pharma firm to cut jobs amid $3 billion cost-reduction plan. Here's what we know
US pharmaceutical company Merck announced on Tuesday that it would cut jobs as part of a cost-reduction plan aimed at saving $3 billion annually by 2027. 'The Company approved a new restructuring program, in which it expects to eliminate certain administrative, sales and R&D positions,' reported AFP, citing a company statement. Merck also lowered its revenue forecast for 2025 slightly. The company did not specify how many posts would be affected, but mentioned that it would continue to hire employees 'into new roles across strategic growth areas of the business.' The plan involves Merck decreasing its "global real estate footprint" and further optimising its manufacturing network. The announcement followed Washington's declaration on Sunday of a trade agreement with the European Union, which established a 15 per cent tariff on most EU imports into the US, including pharmaceuticals. US President Donald Trump previously threatened a 200 per cent tariff on pharmaceuticals, and an investigation into these levies is currently underway. Merck's revenue for the second quarter was $15.8 billion, a 2% decline year-on-year. However, it surpassed Factset's consensus expectations. The company experienced a drop in sales of its HPV vaccine Gardasil. The vaccine generated $1.1 billion in the second quarter, a 55% decrease year-on-year, due to waning demand in China and increased competition from generic drugs in international markets. In contrast, sales of the cancer drug Keytruda, a major player in oncology, rose 9% to nearly $8 billion between April and the end of June. Merck is cutting $3 billion from its annual budget in anticipation of off-brand competition to its top-selling cancer drug, Keytruda. The company announced that it intends to reinvest these savings into the development and launch of new medicines, reported Bloomberg. The company has lost over 30% of its value in the past 12 months amid growing investor concern about its future after Keytruda.
NDTV
23 minutes ago
- NDTV
US Team To Visit India On August 25 For Next Round Of Trade Talks
New Delhi: The US team will visit India on August 25 for the next round of negotiations for the proposed bilateral trade agreement between the two countries, an official said on Tuesday. The official added that the two sides continue to be engaged in an interim trade deal as the August 1 deadline is approaching. August 1 marks the end of the suspension period of tariffs imposed by US President Donald Trump on dozens of countries, including India (26 per cent). "The US team is visiting for the sixth round of talks," the official said. India and the US teams concluded the fifth round of talks for the agreement last week in Washington. India's chief negotiator and special secretary in the Department of Commerce Rajesh Agrawal and Assistant US Trade Representative for South and Central Asia Brendan Lynch held the deliberations. These deliberations are important as both sides are looking at finalising an interim trade deal before August 1. On April 2 this year, Trump announced high reciprocal tariffs. The implementation of high tariffs was immediately suspended for 90 days till July 9 and later until August 1, as America is negotiating trade deals with various countries. India has hardened its position on the US demand for duty concessions on agri and dairy products. New Delhi has, so far, not given any duty concessions to any of its trading partners in a free trade agreement in the dairy sector. Certain farmers' associations have urged the government not to include any issues related to agriculture in the trade pact. India is seeking the removal of this additional tariff (26 per cent). It is also looking at the easing of tariffs on steel and aluminium (50 per cent) and the auto sector (25 per cent). These issues are an important part of the trade pact negotiations. Against these, India has reserved its right under the WTO (World Trade Organization) norms to impose retaliatory duties. The country is also seeking duty concessions for labour-intensive sectors, such as textiles, gems and jewellery, leather goods, garments, plastics, chemicals, shrimp, oil seeds, grapes, and bananas, in the proposed trade pact. On the other hand, the US wants duty concessions on certain industrial goods, automobiles, especially electric vehicles, wines, petrochemical products, agri goods, dairy items, apples, tree nuts, and genetically modified crops. The two countries are looking to conclude talks for the first tranche of the proposed bilateral trade agreement (BTA) by fall (September-October) this year. Before that, they are looking for an interim trade pact. India's merchandise exports to the US rose 22.8 per cent to USD 25.51 billion in the April-June quarter this financial year, while imports rose 11.68 per cent to USD 12.86 billion.
&w=3840&q=100)
Business Standard
30 minutes ago
- Business Standard
Trump targets Aug 1 for global trade deals as EU and China talks go on
President Donald Trump will make his trade deal decisions this week even as separate negotiations with China and the European Union continue, US Commerce chief Howard Lutnick said on Tuesday ahead of Trump's self-imposed Aug. 1 deadline. US and EU officials were still discussing steel and aluminum tariffs as well as digital services regulations following their framework announced on Sunday, Lutnick told CNBC in an interview, adding that talks with China were also "their own thing". "But for the rest of the world, we're going to have things done by Friday," he said in the interview. Asked about remaining uncertainties surrounding the US-EU agreement, Lutnick said Trump was working "to get things done now." He said pharmaceuticals were a key part of the EU deal so that medicines made in European countries home to several major drugmakers would see their products included in the 15 per cent tariff. "It was important for them to have pharmaceuticals be part of the deal at 15 per cent because President Trump is going to come out in the next two weeks with his pharmaceutical policy, and it is going to be higher," he said.
